Patient Guide: Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 23 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06531941
Status: ACTIVE_NOT_RECRUITING
Condition: Hypoparathyroidism
Phase: PHASE2

Where You Can Participate

This study is available at 23 locations across the country.

Top locations include:
  • • Miami, Florida
  • • Macon, Georgia
  • • Jackson, Mississippi
  • • And 20 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Extension Study to Evaluate the Long-Term Safety and Tolerability of MBX 2109 in Patients With Hypoparathyroidism - Join Clinical Trial NCTNCT06531941

How to Join This Clinical Trial - NCTNCT06531941

Learn how to participate in this PHASE2 trial studying an investigational therapy for Hypoparathyroidism. Current status: ACTIVE_NOT_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hypoparathyroidism. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hypoparathyroidism
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
ACTIVE_NOT_RECRUITING
Study Identifier
NCTNCT06531941 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 23 locations. Find a study site near you:

Clinical Research Site

Miami, Florida 33033 - United States

Status: Contact for availability

Clinical Research Site

Macon, Georgia 31210 - United States

Status: Contact for availability

Clinical Research Site

Jackson, Mississippi 39202 - United States

Status: Contact for availability

Clinical Research Site

St Louis, Missouri 63110 - United States

Status: Contact for availability

Clinical Research Site

Las Vegas, Nevada 89148 - United States

Status: Contact for availability

Clinical Research Site

Reno, Nevada 89511 - United States

Status: Contact for availability

Clinical Research Site

Albany, New York 12203 - United States

Status: Contact for availability

Clinical Research Site

New York, New York 10032 - United States

Status: Contact for availability

Clinical Research Site

The Bronx, New York 10467 - United States

Status: Contact for availability

Clinical Research Site

Columbus, Ohio 43201 - United States

Status: Contact for availability

And 13 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Hypoparathyroidism:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships